Skip to main content
OUTCOME
5. Access to services for NCDs and mental health conditions
NCDs and Risk Factors, Mental Health, Violence and Injuries
5. Access to services for NCDs and mental health conditions
Budget
Approved Budget PB (Previous)
21.1
US$ MILLION
Priority

High

Proposed Budget PB (Current)
23.0
US$ MILLION
Related Outputs and Indicators
  • 5.1.a. Number of countries and territories that are implementing evidence-based national guidelines/protocols/standards for the management of NCDs (i.e., cardiovascular disease, cancer, diabetes, and chronic respiratory disease)
    Baseline
    16
    Target
    33
  • 5.2.a. Number of countries and territories that have surveillance systems in place to enable reporting on the global and regional NCD commitments
    Baseline
    14
    Target
    19
  • 5.2.b. Number of countries and territories with implementation plans for population-based surveys on NCDs developed with direct support from PASB
    Baseline
    4
    Target
    11
  • 5.3.a. Number of countries and territories with comprehensive mental health services integrated into primary health care in at least 50% of primary health care facilities
    Baseline
    17
    Target
    29
  • 5.4.a. Number of countries and territories that collect, analyze, and report a core set of mental health indicators within the national health information systems
    Baseline
    9
    Target
    22
  • 5.5.a. Number of countries and territories that have defined a priority list of assistive devices and products
    Baseline
    1
    Target
    5
How PASB will deliver

Key Technical Cooperation Interventions
 

  • Step up leadership
    • Maximize the coherence of work on NCDs, finding synergies between disease groups and risk factors and with other areas such as air pollution and climate change. PASB will work to identify ways to advance multisectoral action.
  • Support countries

    •    Support countries to strengthen the primary health care response to NCDs and mental health, improve integrated service delivery, scale up appropriate interventions, and improve surveillance for NCDs, mental health, disabilities, and substance use disorders. These efforts should take into account the Strategy for the Prevention and Control of Noncommunicable Diseases (Document CSP28/9, Rev. 1), the Policy for Improving Mental Health (Document CSP30/9), the findings of the evaluation of PAHO’s technical cooperation in NCD prevention and control, and the lessons learned from the COVID-19 pandemic. Efforts will be made to hasten the elimination of cervical cancer.
    •    Strengthen integrated approaches to implementing, scaling up, and evaluating evidence-based and cost-effective interventions for NCDs, disabilities, mental health, and substance use. These should include, among others, implementation of the WHO Package of Essential Noncommunicable (PEN) interventions for primary health care and the HEARTS initiative, the strategy for human papillomavirus (HPV) testing and ablative treatment, the CureALL package for childhood cancer, and the Mental Health Gap Action Programme (mhGAP), including its delivery via tele-mental health.
    •    Improve access to rehabilitation and habilitation services and assistive technology by utilizing country-specific measures such as the WHO Rehabilitation in Health Systems: Guide for Action and the WHO assistive technology assessments (ATA-C and rATA). This should include services for people facing long-term consequences of COVID-19.
    •    Improve country capacity for data collection, analysis, surveillance, and monitoring of NCDs and their risk factors, disabilities and rehabilitation, and mental health conditions (including neurological disorders and substance use disorders). PASB will also work to develop metrics to measure and assess the efficiency of its support in this area of work.

  • Produce technical products on norms and standards, data, and research

    • Provide evidence and leverage collaborations to integrate equity, gender, ethnicity, and human rights components in NCD interventions. Equity, access, and quality will continue to be strong drivers to ensure that everyone benefits from screening and early detection, diagnosis, treatment, rehabilitation, and palliative care, in particular the most disadvantaged, marginalized, and hard-to-reach populations.